论文部分内容阅读
目的:分析博利康尼氧气雾化吸入联合普米克令舒治疗小儿毛细支气管炎的临床治疗效果。方法:选取我院83例小儿毛细支气管炎患儿,将其随机划分为2组,对照组46例患儿接受常规地塞米松磷酸钠静脉滴注治疗,治疗组37例患儿接受博利康尼氧气雾化吸入联合普米克令舒治疗,对比2组患儿的临床治疗效果。结果:2组患者实施治疗后,治疗组37例患儿中,显著改善19例,改善17例,无效1例,总有效率为97.3%,对照组46例患儿中,显著改善20例,改善18例,无效8例,总有效率为82.6%,治疗组治疗总有效率显著优于对照组治疗总有效率,对比有统计学意义(P<0.05)。结论:采用博利康尼氧气雾化吸入联合普米克令舒治疗小儿毛细支气管炎,可有效改善患儿的临床病,缩短患者治疗时间,值得临床应用。
OBJECTIVE: To analyze the clinical effect of combination of atomization inhalation of beclomethazole and pulmicort in the treatment of pediatric bronchiolitis. Methods: 83 children with bronchiolitis in our hospital were selected and randomly divided into two groups. 46 children in the control group received routine dexamethasone sodium phosphate intravenous infusion. 37 children in the treatment group received oribacil Oxygen inhalation combined with Pulmicort resveratrol treatment, compared with two groups of children with clinical treatment. Results: In the two groups of 37 patients, the treatment group improved significantly in 19 cases, improved in 17 cases, ineffective in 1 case, the total effective rate was 97.3% in the control group, 46 cases of children, significantly improved in 20 cases, 18 cases were improved, 8 cases were ineffective, and the total effective rate was 82.6%. The total effective rate of the treatment group was significantly better than that of the control group, the difference was statistically significant (P <0.05). CONCLUSION: Adopting combination of atomization inhalation of vicariously with pulmicort and pulmicort respules in children with bronchiolitis can effectively improve children’s clinical disease and shorten the treatment time of patients, which is worthy of clinical application.